These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 35891167)

  • 1. Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron).
    Grüne B; Grüne J; Kossow A; Joisten C
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
    Watson LM
    N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk.
    Hsu L; Hurraß J; Kossow A; Klobucnik J; Nießen J; Wiesmüller GA; Grüne B; Joisten C
    Public Health; 2022 Mar; 204():40-42. PubMed ID: 35152039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12-17 years in Singapore: a national cohort study.
    Chiew CJ; Premikha M; Chong CY; Wei WE; Ong B; Lye DC; Heng D; Lee VJ; Tan KB
    Lancet Infect Dis; 2023 Feb; 23(2):177-182. PubMed ID: 36182678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
    Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B
    Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.
    Tan ST; Kwan AT; Rodríguez-Barraquer I; Singer BJ; Park HJ; Lewnard JA; Sears D; Lo NC
    medRxiv; 2022 Nov; ():. PubMed ID: 36299430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of clinical characteristics of 362 vaccinated or unvaccinated patients infected by novel coronavirus Omicron variant].
    Feng Q; Wang Z; Yu H; Shi L; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):459-464. PubMed ID: 35728844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022.
    Baker JM; Nakayama JY; O'Hegarty M; McGowan A; Teran RA; Bart SM; Mosack K; Roberts N; Campos B; Paegle A; McGee J; Herrera R; English K; Barrios C; Davis A; Roloff C; Sosa LE; Brockmeyer J; Page L; Bauer A; Weiner JJ; Khubbar M; Bhattacharyya S; Kirking HL; Tate JE
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):341-346. PubMed ID: 35238860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy.
    Stufano A; Buonvino N; Trombetta CM; Pontrelli D; Marchi S; Lobefaro G; De Benedictis L; Lorusso E; Carofiglio MT; Vasinioti VI; Montomoli E; Decaro N; Lovreglio P
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis.
    Meggiolaro A; Sane Schepisi M; Farina S; Castagna C; Mammone A; Siddu A; Stefanelli P; Boccia S; Rezza G
    Expert Rev Vaccines; 2022 Dec; 21(12):1831-1841. PubMed ID: 36242513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.
    Wang XJ; Yao L; Zhang HY; Zhu KL; Zhao J; Zhan BD; Li YK; He XJ; Huang C; Wang ZY; Jiang MD; Yang P; Yang Y; Wang GL; Wang SQ; Dai EH; Gao HX; Ma MJ
    Genome Med; 2022 Dec; 14(1):146. PubMed ID: 36581867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany's Largest Public Health Department (Cologne).
    Hsu L; Grüne B; Buess M; Joisten C; Klobucnik J; Nießen J; Patten D; Wolff A; Wiesmüller GA; Kossow A; Hurraß J
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study.
    Monge S; Rojas-Benedicto A; Olmedo C; Mazagatos C; José Sierra M; Limia A; Martín-Merino E; Larrauri A; Hernán MA;
    Lancet Infect Dis; 2022 Sep; 22(9):1313-1320. PubMed ID: 35658998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
    Wan J; Cazer CL; Clarkberg ME; Henderson SG; Lee SE; Meredith GR; Osman M; Shmoys DB; Frazier PI
    PLoS Med; 2023 Jan; 20(1):e1004153. PubMed ID: 36626376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status.
    Moffa MA; Shively NR; Carr DR; Bremmer DN; Buchanan C; Trienski TL; Jacobs MW; Saini V; Walsh TL
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac438. PubMed ID: 36092825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.